Enhanced External Counter-Pulsation Therapy (EECP)
Enhanced external counterpulsation (EECP) therapy is an FDA approved treatment for chest discomfort.
Enhanced external counterpulsation (EECP) therapy is an FDA approved treatment for chest discomfort. It is used to treat chronic stable angina (long-term chest discomfort or pressure) that has not responded to conventional treatments. Some people who need a method to restore blood flow to their heart but aren’t candidates for surgery may benefit from EECP therapy.
Pressure is used in EECP therapy to enhance blood flow. It’s an outpatient, noninvasive treatment. The treatment is usually given over the course of seven weeks.
This form of therapy can help you lessen your reliance on medication while also allowing you to be more active without feeling symptoms. The majority of side effects are minimal. Your healthcare practitioner can help you figure out if you’re a candidate for EECP therapy.
What does EECP treat?
Who is eligible?
Research shows many people report improved symptoms for up to a few years after EECP treatment.
they experience:
Treatment-related complications are usually minimal. The majority of people have no serious side effects, pain, or difficulties. Shortness of breath can occur in rare circumstances, necessitating hospitalization and treatment.
Fatigue and muscle aches are common adverse effects. Because of the equipment, some persons have blisters or moderate skin irritation.
Some may experience:
Book a complimentary Discovery Call Consultation today to learn what’s possible for you and your condition.
